Neoadjuvant Chemoradiation in Patients With Borderline Resectable Pancreatic Cancer
Clinical trial NCT01458717 · COMPLETED
Trial details
- NCT number
- NCT01458717
- Sponsor
- Seoul National University Hospital
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-11-01
- Primary completion
- 2018-01-01
- Enrollment
- 58
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.